Bristol-Myers Squibb

EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer
Thu, 05/3/18 - 09:24 am
Bristol-Myers Squibb
non-small cell lung cancer
Opdivo
Yervoy
A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins
Medical Marketing and Media
Wed, 05/2/18 - 12:01 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers
Forbes
Wed, 05/2/18 - 10:49 am
Flatiron Health
M&A
Roche
Bristol-Myers Squibb
real-world evidence
Bristol-Myers profit tops Street view, raises 2018 forecast
Reuters
Thu, 04/26/18 - 10:10 am
Bristol-Myers Squibb
earnings
Immunotherapies, biosimilars to dominate next week of earnings
Biopharma Dive
Tue, 04/24/18 - 10:50 pm
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Vertex Pharmaceuticals
Sanofi
earnings
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
CP Wire
Tue, 04/17/18 - 09:23 am
Bristol-Myers Squibb
Janssen
Factor XIa
stroke
Bristol's Opdivo-Yervoy duo snares a quick FDA nod in first-line kidney cancer
Fierce Pharma
Mon, 04/16/18 - 11:36 pm
Bristol-Myers Squibb
Opdivo
Yervoy
kidney cancer
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
Mon, 04/16/18 - 07:28 pm
Bristol-Myers Squibb
Janssen
Factor XIa
stroke
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
CNBC
Mon, 04/16/18 - 09:46 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
non-small cell lung cancer
AACR
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
Sun, 04/15/18 - 10:04 pm
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Forbes
Sat, 04/14/18 - 01:18 pm
Bristol-Myers Squibb
Illumina
DNA sequencing
Opdivo
diagnostics
With big Keytruda and Opdivo data coming at AACR, analyst hands Merck the early edge
Fierce Pharma
Fri, 04/13/18 - 12:55 pm
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
AACR
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Fri, 04/13/18 - 08:52 am
Pfizer
M&A
Bristol-Myers Squibb
Celgene
Eli Lilly
AstraZeneca
Trust me, Pfizer isn't interested in buying BMS, analyst says—at least not yet
Fierce Pharma
Thu, 04/12/18 - 11:54 am
Pfizer
M&A
Ian Read
Bristol-Myers Squibb
Physician payments linked to scripts for cancer drugs from Novartis, Pfizer and more: study
Fierce Pharma
Tue, 04/10/18 - 10:30 pm
physician payments
Novartis
Pfizer
Bayer
Bristol-Myers Squibb
cancer
PDUFA test
Tue, 04/10/18 - 12:16 am
How a Biotech Bummer Sent Nektar Therapeutics Stock South Today
Motley Fool
Fri, 04/6/18 - 07:41 pm
Nektar Therapeutics
Incyte
Merck
NKTR-214
Bristol-Myers Squibb
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
CP Wire
Fri, 04/6/18 - 12:00 am
metastatic non-small cell lung cancer
Altor Bioscience
ALT-803
Opdivo
Bristol-Myers Squibb
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
Thu, 04/5/18 - 11:40 pm
Opdivo
ALT-803
Bristol-Myers Squibb
Altor Bioscience
Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
Motley Fool
Wed, 04/4/18 - 08:59 am
Big Pharma
Pharma CEOs
executive pay
AbbVie
Bristol-Myers Squibb
Gilead Sciences
JNJ
Pfizer

Pages